The Securities and Exchange Commission (SEC) on Thursday charged the former chief financial officer of biopharmaceutical company Immunomedics (IMMU) and his former romantic partner with insider trading.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...